These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15659971)

  • 41. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
    Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
    PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevenar experience.
    Arguedas A; Soley C; Abdelnour A
    Vaccine; 2011 Sep; 29 Suppl 3():C26-34. PubMed ID: 21896350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review.
    Bressan S; Berlese P; Mion T; Masiero S; Cavallaro A; Da Dalt L
    Acta Paediatr; 2012 Mar; 101(3):271-7. PubMed ID: 21950707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
    Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
    Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antipneumococcal vaccine: up date and prospective].
    Caramia G; Pastorelli G
    Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fever without apparent source on clinical examination.
    McCarthy PL
    Curr Opin Pediatr; 2004 Feb; 16(1):94-106. PubMed ID: 14758122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
    Savulescu C; Krizova P; Lepoutre A; Mereckiene J; Vestrheim DF; Ciruela P; Ordobas M; Guevara M; McDonald E; Morfeldt E; Kozakova J; Varon E; Cotter S; Winje BA; Munoz-Almagro C; Garcia L; Castilla J; Smith A; Henriques-Normark B; Celentano LP; Hanquet G;
    Lancet Respir Med; 2017 Aug; 5(8):648-656. PubMed ID: 28359798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in pneumococcal vaccines: advantages for infants and children.
    Bernatoniene J; Finn A
    Drugs; 2005; 65(2):229-55. PubMed ID: 15631543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults.
    Shafinoori S; Ginocchio CC; Greenberg AJ; Yeoman E; Cheddie M; Rubin LG
    Pediatr Infect Dis J; 2005 Jan; 24(1):10-6. PubMed ID: 15665704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
    Stoll ML; Rubin LG
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types.
    Browall S; Backhaus E; Naucler P; Galanis I; Sjöström K; Karlsson D; Berg S; Luthander J; Eriksson M; Spindler C; Ejdebäck M; Trollfors B; Darenberg J; Kalin M; Örtqvist A; Andersson R; Henriques-Normark B
    Eur Respir J; 2014 Dec; 44(6):1646-57. PubMed ID: 25323223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumococcal conjugated vaccine: PHiD-CV.
    Dinleyici EC; Yargic ZA
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1063-74. PubMed ID: 19883326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.
    Bos JM; Rümke HC; Welte R; Spanjaard L; van Alphen L; Postma MJ
    Pharmacoeconomics; 2006; 24(2):141-53. PubMed ID: 16460135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.
    Ceyhan M; Ozsurekci Y; Gürler N; Öksüz L; Aydemir S; Ozkan S; Yuksekkaya S; Keser Emiroglu M; Gültekin M; Yaman A; Kiremitci A; Yanık K; Karli A; Ozcinar H; Aydin F; Bayramoglu G; Zer Y; Gulay Z; Gayyurhan ED; Gül M; Özakın C; Güdücüoğlu H; Perçin D; Akpolat N; Ozturk C; Camcıoğlu Y; Karadağ Öncel E; Çelik M; Şanal L; Uslu H
    Hum Vaccin Immunother; 2016; 12(2):308-13. PubMed ID: 26325175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children.
    Lieu TA; Ray GT; Black SB; Butler JC; Klein JO; Breiman RF; Miller MA; Shinefield HR
    JAMA; 2000 Mar; 283(11):1460-8. PubMed ID: 10732936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pneumococcal bacteremia in children: an 8-year review in two hospitals in Barcelona.
    Pérez A; Sala P; Giménez M; Sierra M; Esteve A; Alonso A; Quesada M; Raspall F; Ausina V; Rodrigo C
    Eur J Clin Microbiol Infect Dis; 2004 Sep; 23(9):677-81. PubMed ID: 15322935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.